Cargando…

An Early CD4(+) T Cell–dependent Immunoglobulin A Response to Influenza Infection in the Absence of Key Cognate T–B Interactions

Contact-mediated interactions between CD4(+) T cells and B cells are considered crucial for T cell–dependent B cell responses. To investigate the ability of activated CD4(+) T cells to drive in vivo B cell responses in the absence of key cognate T–B interactions, we constructed radiation bone marrow...

Descripción completa

Detalles Bibliográficos
Autores principales: Sangster, Mark Y., Riberdy, Janice M., Gonzalez, Maricela, Topham, David J., Baumgarth, Nicole, Doherty, Peter C.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194225/
https://www.ncbi.nlm.nih.gov/pubmed/14517272
http://dx.doi.org/10.1084/jem.20021745
Descripción
Sumario:Contact-mediated interactions between CD4(+) T cells and B cells are considered crucial for T cell–dependent B cell responses. To investigate the ability of activated CD4(+) T cells to drive in vivo B cell responses in the absence of key cognate T–B interactions, we constructed radiation bone marrow chimeras in which CD4(+) T cells would be activated by wild-type (WT) dendritic cells, but would interact with B cells that lacked expression of either major histocompatibility complex class II (MHC II) or CD40. B cell responses were assessed after influenza virus infection of the respiratory tract, which elicits a vigorous, CD4(+) T cell–dependent antibody response in WT mice. The influenza-specific antibody response was strongly reduced in MHC II knockout and CD40 knockout mice. MHC II–deficient and CD40-deficient B cells in the chimera environment also produced little virus-specific immunoglobulin (Ig)M and IgG, but generated a strong virus-specific IgA response with virus-neutralizing activity. The IgA response was entirely influenza specific, in contrast to the IgG2a response, which had a substantial nonvirus-specific component. Our study demonstrates a CD4(+) T cell–dependent, antiviral IgA response that is generated in the absence of B cell signaling via MHC II or CD40, and is restricted exclusively to virus-specific B cells.